Department of Rehabilitation Medicine, School of Medicine, 26723Kyung Hee University, Seoul, Republic of Korea.
Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, 26723Kyung Hee University, Seoul, Republic of Korea.
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211042124. doi: 10.1177/20587384211042124.
The effectiveness of the combination of steroids and antiviral agents in the treatment of Bell's palsy remains unclear. This study evaluated the therapeutic effect of combination therapy in severe Bell's palsy patients and assesses specific conditions under which combination therapy is more effective than steroids alone.
From January 2005 to December 2019, the records of 1710 Bell's palsy patients who visited Kyung Hee University Hospital were reviewed retrospectively. Of these, 335 (19.6%) patients were diagnosed with severe Bell's palsy, with 162 patients treated with steroids alone and 173 patients treated with combinations of steroids and antiviral agents. The outcomes of treatment were assessed using the House-Brackmann (H-B) grade according to age, sex, hypertension, diabetes, and obesity.
The favorable recovery rate was significantly higher in severe Bell's palsy patients who were treated with combinations of steroids and antiviral agents than with steroids alone (78.0% vs. 66.7%, = 0.020). Subgroup analysis showed that combination therapy resulted in significantly higher recovery rates than steroids alone in patients aged ≥40 years (77.5% vs. 64.1%, = 0.023) and in those without hypertension (75.8% vs. 63.3%, = 0.044) and diabetes (79.7% vs. 65.5%, = 0.007).
Combination therapy with steroids and antiviral agents resulted in significantly higher favorable recovery rates than steroids alone in severe Bell's palsy patients. Combination therapy was particularly more effective than steroids alone in patients aged ≥40 years and in patients without hypertension and diabetes.
皮质类固醇激素和抗病毒药物联合治疗贝尔麻痹的疗效尚不清楚。本研究评估了联合治疗在重症贝尔麻痹患者中的治疗效果,并评估了联合治疗比单独使用皮质类固醇激素更有效的具体情况。
回顾性分析 2005 年 1 月至 2019 年 12 月在庆熙大学医院就诊的 1710 例贝尔麻痹患者的病历,其中 335 例(19.6%)患者被诊断为重症贝尔麻痹,162 例患者给予皮质类固醇激素治疗,173 例患者给予皮质类固醇激素联合抗病毒药物治疗。根据年龄、性别、高血压、糖尿病和肥胖,采用 House-Brackmann(H-B)分级评估治疗结果。
与单独使用皮质类固醇激素治疗相比,联合使用皮质类固醇激素和抗病毒药物治疗的重症贝尔麻痹患者的良好恢复率显著更高(78.0% vs. 66.7%, = 0.020)。亚组分析显示,联合治疗在年龄≥40 岁的患者(77.5% vs. 64.1%, = 0.023)和无高血压(75.8% vs. 63.3%, = 0.044)和糖尿病(79.7% vs. 65.5%, = 0.007)患者中,恢复率显著高于单独使用皮质类固醇激素。
与单独使用皮质类固醇激素相比,皮质类固醇激素联合抗病毒药物治疗重症贝尔麻痹患者的良好恢复率显著更高。联合治疗在年龄≥40 岁的患者和无高血压、糖尿病的患者中比单独使用皮质类固醇激素更有效。